Personalized Interrogation of the Human Epigenome

Virtual Lecture

Expires: March 23, 2024


In this month’s “Virtual Lecture,” Mrinal Patnaik, M.B.B.S., will explore the translational value of epigenomics by defining epigenetics and chromatin biology, discussing techniques and measures to assess chromatic biology with a special focus on the epigenetics development laboratory, and give examples on how to bring the epigenome from the bench to the bedside.



Mrinal Patnaik, M.B.B.S.

Associate Professor of Medicine and Assistant Professor of Oncology
Mayo Clinic College of Medicine and Science
Division of Hematology
Director of CIM Epigenomics Program
Chair, Acute Leukemia and Myeloid Neoplasms Disease Group
Mayo Clinic, Rochester, Minnesota

Learning objectives

Upon completion of this program, participants should be able to:

  • Define epigenetics and chromatin biology.
  • Describe techniques and measures to assess chromatin biology and epigenetic alterations.
  • Summarize examples of applicability in clinical practice for diagnosis, prognosis, and therapeutics.

Intended audience

This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.


The following types of credit are offered for this program:


Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of .5 P.A.C.E.® contact hour.

To obtain credit

1. Watch the video.

2. Complete the post-test and evaluation that launches immediately following the video.

3. Generate and print your certificate(s).

Level of instruction for this program is intermediate.

Faculty disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.


Contact us:

Image credit: Getty Images

MCL Education (@mmledu)

MCL Education

This post was developed by our Education and Technical Publications Team.